Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Emtnester, Thank you for posting their reply. here is an

No problem at all...many here do the same thing and I appreciate all those who do...esp those with more insight to certain issues than myself...

It does answer a few things though...1.It tells us not to expect too much on Crossflo before the annual..2.that no Preferred shares are being used for Crossflo...3. that these shares are restricted for most of the shareholders I think that a previosus communique said, 6 months,,,which in turn tells us.that .4. there is iNO nflux on the selling side due to these shares being issued at least for another six months or so and maybe never if those holding them decide to retain them for a later selling price.

Share
New Message
Please login to post a reply